Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathogenesis of osteoporosis.

Lawrence G Raisz1, Gideon A Rodan

  • 1Division of Endocrinology and Metabolism, Department of Medicine, University of Connecticut Health Center, 263 Farmington Avenue, MC 1850, Farmington, CT 06030-1850, USA. raisznso.uchc.edu

Endocrinology and Metabolism Clinics of North America
|April 18, 2003
PubMed
Summary

Osteoporosis involves complex pathways affecting bone mass and fracture risk. Research using genomics and proteomics aims to identify new mechanisms for better diagnosis and treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Physiological and Pharmacologic Regulation of Bone Resorption-A 1978 Update.

Journal of periodontology·2018
Same author

Basal bone phenotype and increased anabolic responses to intermittent parathyroid hormone in healthy male COX-2 knockout mice.

Bone·2010
Same author

Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women.

The Journal of clinical endocrinology and metabolism·2010
Same author

Prostaglandins in bone: bad cop, good cop?

Trends in endocrinology and metabolism: TEM·2010
Same author

The discovery of MK-0674, an orally bioavailable cathepsin K inhibitor.

Bioorganic & medicinal chemistry letters·2010
Same author

Identification of anabolic selective androgen receptor modulators with reduced activities in reproductive tissues and sebaceous glands.

The Journal of biological chemistry·2009

Area of Science:

  • Bone biology and osteoporosis research.

Background:

  • Osteoporosis is characterized by decreased bone mass, skeletal fragility, and increased fracture risk.
  • Established causes include estrogen deficiency, while others like cytokine and growth factor abnormalities are speculative.

Purpose of the Study:

  • To explore diverse pathogenetic mechanisms contributing to osteoporosis.
  • To leverage advancements in genomics and proteomics for in-depth investigation of osteoporosis pathways.

Main Methods:

  • Review of established and speculative pathways in osteoporosis.
  • Utilizing insights from genomics and proteomics.
  • Employing animal models (rodents, primates) for studying pathogenetic factors.

Main Results:

  • Identified estrogen deficiency as a key factor.

Related Experiment Videos

  • Highlighted speculative roles of cytokines, bone growth factors, and osteoblast transcription factors.
  • Genomics and proteomics offer new research avenues.

    • Conclusions:

    • Understanding diverse pathogenetic mechanisms is crucial for osteoporosis.
    • Animal models aid in identifying factors for human studies.
    • Identifying specific mechanisms will advance osteoporosis diagnosis and management.